ABC Heart Fail Cardiomyop 2022; 2(3): 296-298
Pathophysiological Bases of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction and Implications for Management
Aguinaldo F. Freitas Jr.
, Daniela do Carmo Rassi Frota
, Salvador Rassi
Pulmonary hypertension (PH) associated with left heart disease is classified as group 2, and it encompasses both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).1 In both diseases, the development of PH is associated with an unfavorable clinical course in the natural history of the disease, and knowledge about its pathophysiology is still uncertain, which may have practical implications from the diagnosis to the treatment of heart failure.2,3
[…]
Keywords: Heart Failure; HFpEF; Pulmonary Hypertension
500
